ProductLife Group provides development, regulatory affairs, market access, pharmacovigilance, quality management and digital transformation services mainly to clients in the pharmaceuticals industry.
Add-on acquisitions
16
over the last four years
Clients
>1,000
Globally
Operates in
150+
Countries
ProductLife Group provides development, regulatory affairs, market access, pharmacovigilance, quality management and digital transformation services mainly to clients in the pharmaceuticals industry.
The business has a diversified customer base with over 1,000 clients including 75% of the 50 largest global pharma companies.
Under the leadership of Xavier Duburcq, ProductLife Group has grown significantly over the last four years, completing 16 add-on acquisitions and generating double-digit organic revenue growth. Today, ProductLife Group employs more than 1,600 people and operates across 150+ countries globally.
Oakley will work alongside management and the reinvesting shareholder, 21 Invest, leveraging our buy-and-build track record, supporting the business’ continued international expansion and accelerating investments into AI technology to drive technology enablement of its services and operations.
Xavier Duburcq
CEO — ProductLife Group
The regulatory and compliance sector within the life sciences industry is a large, non-cyclical market where increased regulation and outsourcing are driving growth. The sector expects a shift towards Ai powered solutions, ProductLife group's investment in technology enablement gives the company a competitive advantage.